Why the study?
There is disagreement regarding cardio-pulmonary injury and functional impairment due to SARS-CoV-2 during mid-term follow-up.
Mid-term cardiopulmonary assessment in COVID-19 survivors adds data; leaves open clinical relevance and need for prospective validation.
Although many studies suggest different degrees of myocardial and pulmonary injury during the acute infection and early follow-up [1–3],there is disagreement about cardio-pulmonary injury and functional impairment due to Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) during mid-term follow-up [4–8]. We attempt to evaluate the cardiopulmonary function and assess the pulmonary and myocardial injury objectively in SARS-CoV-2 survivors.
No takes yet. Share an insight, caveat, or question.
Vannini et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: